#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinal artery occlusion Salivary gland cancer Allogenic stem cell transplantation Soft tissue sarcoma Hereditary optic atrophy Prader-Willi syndrome Spinal cord injury cervical Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Acquired C1 inhibitor deficiency Immune-mediated renal disorder Huntington's disease Neuroendocrine tumour of the lung Laryngeal squamous cell carcinoma Amyotrophic lateral sclerosis Waldenstrom's macroglobulinaemia More trials…

    Learn about Rare Diseases

    Burkitt’s lymphoma – Basic Information Testicular leiomyosarcoma – Diagnostics Thrombotic thrombocytopenic purpura – Diagnostics Methylmalonic acidaemia – Diagnostics Progressive supranuclear palsy – Basic Information Hairy cell leukaemia – Treatment Alagille syndrome – Basic Information Myelodysplastic syndrome with excess blasts – Trials in Disease Sjogren’s syndrome Factor IX deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tabelecleucel Mk-1084 Degarelix Acetate IMMUNOSTEM Autologous Pancreatic Islets L-Glutamic Acid Sotatercept Bemnifosbuvir Hemisulfate Ht-29-B Triptorelin Pamoate Bms-986458 [18F]Fluoro-Peg-Folate Potassium Iodide Triamcinolone Acetonide Indocyanine Green Disulfiram Mycophenolate Mofetil Disodium Folinate [68GA]GA-NOTA-AE105 Lovo-A More therapies…

    Learn about Your Condition

    Lichen planopilaris Anal cancer Pancreatic carcinoma Seasonal allergy Double hit lymphoma Malignant melanoma stage III Cold type haemolytic anaemia Polymyositis Acute on chronic liver failure Plasma cell leukaemia Diabetic foot Escherichia infection Corneal graft rejection Spinal cord injury cervical Endocarditis enterococcal More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Victor Dupouy

Centre Hospitalier Victor Dupouy

69 Rue Du Lieutenant Colonel Prudhon, Argenteuil, 95107, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Beclometasone Dipropionate
    France Germany Italy Spain

  • Fosfomycin trometamol versus drug combination for treating acute E. coli pyelonephritis in women aged 75 years and older

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyelonephritis
    Investigated Drugs:
    • Cefoxitin
    • Cilastatin Sodium
    • Ertapenem Sodium
    France

  • Fosfomycin versus drug combination for oral step‑down treatment of febrile urinary tract infections caused by E. coli in men

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Escherichia urinary tract infection
    Investigated Drugs:
    • Fosfomycin
    • Tolu Balsam
    • Ciprofloxacin Hydrochloride
    France

  • Early Use of Dexamethasone versus Sodium Chloride Placebo in Patients with Severe Influenza-Induced Acute Hypoxemic Respiratory Failure (Phase III Randomized Trial)

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Pneumonia
    • Influenza
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Sodium Chloride
    France

  • Evaluating venetoclax with drug combination in relapsed/refractory T‑cell acute lymphoblastic leukemia patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • T-cell type acute leukaemia
    Investigated Drugs:
    • Everolimus
    • Azacitidine
    • Tofacitinib
    Czechia France Germany The Netherlands Spain

  • Early Saline Pleural Irrigation for Patients with Complicated Pleural Infections

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infectious pleural effusion
    Investigated Drugs:
    • Urokinase
    • Clindamycin Phosphate
    • Alteplase
    France

  • Study of ketamine hydrochloride to improve recovery in adults requiring unplanned mechanical ventilation in the intensive care unit

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Mechanical ventilation
    Investigated Drugs:
    • Ketamine Hydrochloride
    • Sodium Chloride
    France

  • A study of belantamab mafodotin and mezigdomide in patients with relapsed multiple myeloma who have previously received CAR-T cell therapy or bispecific antibodies

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Belantamab Mafodotin
    • Mezigdomide
    France

  • Comparing the timing of etoposide and dexamethasone treatment for patients with severe sporadic hemophagocytic lymphohistiocytosis in intensive care.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophagocytic lymphohistiocytosis
    Investigated Drugs:
    • Dexamethasone Acetate
    • Etoposide
    France

  • A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Aciclovir
    • Linvoseltamab
    • Bortezomib
    Austria Belgium Czechia France Germany Greece +4
Previous Page
1 2 3 4 5 6 … 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!